Peripheral Neuropathy Trial, Recruiting (NCT06822231)

Peripheral Neuropathy Trial, Recruiting NCT06822231 Sponsor: Istituti Clinici Scientifici Maugeri SpA Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT06822231 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 80 years old.
You have been diagnosed with an acute or subacute neuromuscular disease (a condition affecting the nerves and muscles that came on recently), such as Guillain-Barré Syndrome (GBS), or muscle/nerve damage related to critical illness.
Your symptoms started between 15 and 30 days ago.
You have at least some muscle strength remaining in your legs — specifically, at least a minimal level of movement in the hip, knee, or ankle muscles (confirm with trial site for exact strength assessment).
You are able to give your consent to take part in the study.

Who may not be able to join:

You have a serious unstable health condition — for example, a very severe heart condition or breathing difficulties that cannot be managed with ventilation support — that a doctor believes would make it unsafe for you to participate.
You are currently taking part in another clinical trial that might affect this study.
You are pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +39 0250725266

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06822231

Sponsor: Istituti Clinici Scientifici Maugeri SpA

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: +39 0250725266

More information: https://clinicaltrials.gov/study/NCT06822231

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 80 years old.
You have been diagnosed with an acute or subacute neuromuscular disease (a condition affecting the nerves and muscles that came on recently), such as Guillain-Barré Syndrome (GBS), or muscle/nerve damage related to critical illness.
Your symptoms started between 15 and 30 days ago.
You have at least some muscle strength remaining in your legs — specifically, at least a minimal level of movement in the hip, knee, or ankle muscles (confirm with trial site for exact strength assessment).
You are able to give your consent to take part in the study.

Who may not be able to join:

You have a serious unstable health condition — for example, a very severe heart condition or breathing difficulties that cannot be managed with ventilation support — that a doctor believes would make it unsafe for you to participate.
You are currently taking part in another clinical trial that might affect this study.
You are pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Istituti Clinici Scientifici Maugeri SpA

Registry

ClinicalTrials.gov

Start date

28 May 2025

Est. completion

1 August 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Change from baseline in Berg Balance Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov